Reasoning is an ability that is unique to human cognition. However, despite our advances in neuroimaging techniques, we cannot clearly map the neural regions involved in human reasoning. In a new study, researchers from Korea came up with a new approach to understand the foundations of both inductive and deductive reasoning and identify the major
Researchers in the Department of Neurology at Tohoku University, which is led by professor Masashi Aoki, have developed a classification scheme for neuromyelitis optica spectrum disorder, a rare autoimmune disease that until recently was thought to be a type of multiple sclerosis (MS). The new taxonomy for the disease replaces one borrowed from MS but
Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis (MS), according to a Northwestern Medicine study published in eLife. There are currently no FDA-approved drugs that have been shown to effectively regenerate this coating, called myelin. This new strategy could
A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple myeloma, according to findings from a multi-institutional phase I study being presented by Alfred L. Garfall, MD, an assistant professor of Medicine in the division of Hematology-Oncology in the
Researchers from the University of Vermont (UVM) have found that a bacterial species called Lactobacillus reuteri, commonly used in probiotics, can increase disease severity in a mouse model of multiple sclerosis (MS), an autoimmune disease that is the leading cause of non-traumatic neurological disability in young adults. But don’t throw away your yogurt just yet.
Scientists from Trinity College Dublin have made an important discovery that could lead to more effective treatments for people living with multiple sclerosis (MS) and other autoimmune diseases such as psoriasis and rheumatoid arthritis. Their work highlights the significant potential of drugs targeting a specific immune molecule (IL-17) implicated in MS. The scientists, led by
There is uncertainty regarding the effect of exercise and other interventions on the prevention of falls in patients with multiple sclerosis (MS), according to a review published online Nov. 28 in the Cochrane Database of Systematic Reviews. Sara Hayes, Ph.D., from the University of Limerick in Ireland, and colleagues conducted a systematic literature review to
Boosting brain function is key to staving off the effects of aging. And if there was one thing every person should consider doing right now to keep their brain young, it is to add extra virgin olive oil (EVOO) to their diet, according to research by scientists at the Lewis Katz School of Medicine at
Researchers at the Johns Hopkins Kimmel Cancer Center have developed a simple new blood test that can detect the presence of seven different types of cancer by spotting unique patterns in the fragmentation of DNA shed from cancer cells and circulating in the bloodstream. In a proof-of-concept study, the test, called DELFI (DNA evaluation of
(HealthDay)—The selective Bruton’s tyrosine kinase (BTK) inhibitor evobrutinib at a dose of 75 mg once daily is associated with fewer enhancing lesions during weeks 12 through 24 among patients with relapsing multiple sclerosis, according to a study published May 10 in the New England Journal of Medicine to coincide with the annual meeting of the
A molecule that helps blood clot may also play a role in multiple sclerosis relapses, researchers report in the May 6 issue of PNAS. The new research may help answer the mystery of why remissions happen, as well as find early markers of the disease. The research also shows a new way to study multiple
For some women, having multiple orgasms is the sexual Mount Everest of pleasure. However, Stella Harris, Intimacy Educator, Sex Coach, and author of Tongue Tied: Untangling Communication in Sex, Kink, and Relationships, tells SheKnows that multiple orgasms can be a bit of a misnomer. “The orgasms don’t necessarily happen one right after the other,” she
New findings by researchers at Cardiff University suggest that intensive therapy during the early stages of multiple sclerosis (MS) leads to better long-term outcomes for patients, despite it often being viewed as a riskier option than other first line treatments. Dr. Emma Tallantyre, from Cardiff University’s Division of Psychological Medicine and Clinical Neurosciences, said: “Over
The grandchildren of adolescent mothers have lower school readiness scores than their peers, according to a study published February 6, 2019 in the open-access journal PLOS ONE by Elizabeth Wall-Wieler of Stanford University and colleagues at the University of Manitoba. Previous studies have established that children born to adolescent mothers are less ready for school
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis (MS). Myelin sheaths are the “insulating tape” surrounding axons; axons carry electrical impulses in neurons. The research demonstrates that myelin sheaths undergo structural transitions when triggered by changes
MONDAY, Sept. 24, 2018 — Multiple pathways account for the age-related increases in dementia risk, according to a study recently published in the Annals of Neurology. Melinda C. Power, Sc.D., from the George Washington University Milken Institute School of Public Health in Washington, D.C., and colleagues used data from 1,362 autopsied participants of three community-based
Thousands will be denied £19,000-a-year drug for multiple sclerosis Thousands will be denied £19,000-a-year drug for multiple sclerosis which could keep them out of a wheelchair because it’s too expensive for the NHS Ocrelizumab is the first-ever drug to effectively treat primary progressive MS But NHS rationing watchdog NICE said £9,600 price rag did not
Researchers at the University of Alberta have discovered a unique process of brain cell death that affects the cells that are most vulnerable in multiple sclerosis (MS). After identifying the process called pyroptosis, or fiery death, the researchers were able to block the enzyme in the brain that is responsible for it, using a drug
Inflammation can be good. It’s part of the body’s innate immune system, our first line of defense against illness and injury. However, if the inflammatory response goes on for too long, it can lead to a condition called chronic inflammation, where the body essentially attacks itself, wreaking biological havoc on our organs and systems. Chronic
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published April 27 in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok